Burn Relief Aloe

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Burn Relief Aloe
Generic name: LIDOCAINE HCL
Manufacturer: Acutens
Product type: HUMAN OTC DRUG
SPL set ID: 48c435fe-2670-4b80-bf01-923dc9354422
SPL ID: 47e3e7d1-e703-b56c-e063-6294a90a8f8a
Version: 7
Effective date: 2026-01-08
Source export date: 2026-09-28
Source partition: 2
Source file: https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/f7d2b6e3f8600cd856280ab55a9c6fa54a642647191d164f9d1110e89f3f4097/drug-label-0002-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:14:55

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Burn Relief Aloe	openfda.brand_name
generic name		LIDOCAINE HCL	openfda.generic_name
manufacturer name		Acutens	openfda.manufacturer_name
ndc	package	80551-001-03	openfda.package_ndc
ndc	product	80551-001	openfda.product_ndc
ndc11	package	80551000103	derived:openfda.package_ndc
rxcui		1010077	openfda.rxcui
spl id		47e3e7d1-e703-b56c-e063-6294a90a8f8a	id
spl set id		48c435fe-2670-4b80-bf01-923dc9354422	set_id
unii		V13007Z41A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product • Avoid contact with eyes. Rinse with water if contact occurs. Stop use and ask doctor if • symptoms persist for more than 7 days or clear up and occur again within a few days. Do not use in large quantities, particularly over raw surfaces or blistered area

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.